Results 231 to 240 of about 9,522 (255)

Latanoprost and herpes simplex keratitis

American Journal of Ophthalmology, 1999
To report three cases in which herpes simplex keratitis developed after initiation of latanoprost therapy.Case report.One patient with a history of herpes simplex keratitis had recurrence of herpes simplex keratitis with latanoprost treatment, resolution when latanoprost was stopped, and another recurrence when rechallenged with latanoprost.
Martin Wand, Martin Wand, C.Mitchell Gilbert, C.Mitchell Gilbert, Thomas J. Liesegang   +4 more
openaire   +2 more sources

Hypertension secondary to treatment with latanoprost

Archivos de la Sociedad Española de Oftalmología (English Edition), 2015
An 80 year old woman operated on by trabeculectomy for primary open-angle glaucoma due to increased pressure, who started treatment with latanoprost. Monitoring of blood pressure (BP) showed a statistically significant increase in both systolic and diastolic BP, coinciding with the use of topical hypotensive, which resolved by voluntarily suspending ...
S. García-Sáenz, Julian Garcia-Feijoo, Jose M. Martinez-de-la-Casa, L. Palmero-Fernández, Enrique Santos-Bueso, Julian Garcia-Sanchez, Federico Saenz-Frances   +6 more
openaire   +3 more sources

Latanoprost-induced Skin Depigmentation

Journal of Glaucoma, 2017
Latanoprost, and other prostaglandin analogs, have been previously associated with increased pigmentary reactions on the periocular skin. Here, we present a patient with paradoxical depigmentation of periocular skin within 1 year of latanoprost use in both eyes. This report is the first to document such an association, and clinicians should be aware of
Mark Lin, Mason Schmutz, Sameh Mosaed
openaire   +2 more sources

Latanoprost (Xalatan®) induziertes Makulaödem

Klinische Monatsblätter für Augenheilkunde, 1998
BACKGROUND: Latanoprost represents a new therapeutic option in the treatment of chronic open angle glaucoma. It has only recently been reported for the first time that latanoprost caused cystoid macular edema in pseudophakic patients. CASE REPORT: A 60-year-old pseudophakic patient who suffered from a 10-year history of glaucoma, revealed a cystoid ...
Alexander Reis, Rainer Sundmacher, Christoph Althaus   +2 more
openaire   +2 more sources

Effects of latanoprost on rodent intraocular pressure

Experimental Eye Research, 2006
The aim of the present study was to evaluate the effects of the prostaglandin F2 alpha analog, latanoprost, on the intraocular pressure (IOP) in rodent eyes. Rodents have been increasingly used in glaucoma research; however, conflicting results regarding the actions of prostaglandins on rodent IOP have been published.
N. Andy Whitlock, Dennis S. Rice, Shahid Husain, Craig E. Crosson   +3 more
openaire   +2 more sources

Latanoprost and Hyperpigmentation of Eyelashes

Archives of Ophthalmology, 1997
Latanoprost (Xalatan, Pharmacia Upjohn Co, Kalamazoo, Mich) is the first new class of antiglaucoma medication introduced in 20 years. Initial reports about its ocular hypotensive effects seem to be promising, but it has an intriguing side effect of increasing iris pigmentation.
openaire   +2 more sources

Latanoprost Versus Combined Timolol and Dorzolamide

Survey of Ophthalmology, 2002
We reviewed available data comparing latanoprost and combined timolol and dorzolamide and the additive effect of latanoprost in patients receiving timolol and dorzolamide in combination using a literature search through the electronic Medline database and presentations from proceedings of recent glaucoma meetings.
Bron, Alain, M., Emmerich, Karl-Heinz
openaire   +5 more sources

Latanoprost-Loaded Phytantriol Cubosomes for the Treatment of Glaucoma.

European Journal of Pharmaceutical Sciences, 2021
C. Bessone, Seyedeh Parinaz Akhlaghi, L. Tártara, D. Quinteros, W. Loh, D. Allemandi   +5 more
semanticscholar   +1 more source

Efficacy of topical latanoprost versus minoxidil and betamethasone valerate on the treatment of alopecia areata

Journal of dermatological treatment (Print), 2018
Background: Alopecia areata (AA) is one of the most common causes of localized hair loss. There is no universally proven therapy that induces and sustains remission of hair growth in AA.
A. El-Ashmawy, Iman Hamed El-Maadawy, G. M. El-Maghraby   +2 more
semanticscholar   +1 more source

The Effect of Latanoprost on Circadian Intraocular Pressure

Survey of Ophthalmology, 2002
The presence of a circadian variation of both intraocular pressure (IOP) and aqueous humor flow has been demonstrated in several studies. It must therefore be considered important to monitor IOP and evaluate the efficacy of ocular hypotensive drugs over the 24 hours of the day.
L. I. Larsson, H. K. Mishima, M. Takamatsu, N. Orzalesi, L. Rossetti   +4 more
openaire   +3 more sources